271 related articles for article (PubMed ID: 14702244)
1. Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative.
Marder SR; Fenton W; Youens K
Am J Psychiatry; 2004 Jan; 161(1):25. PubMed ID: 14702244
[No Abstract] [Full Text] [Related]
2. The MATRICS initiative: developing a consensus cognitive battery for clinical trials.
Green MF; Nuechterlein KH
Schizophr Res; 2004 Dec; 72(1):1-3. PubMed ID: 15531401
[No Abstract] [Full Text] [Related]
3. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.
Marder SR; Fenton W
Schizophr Res; 2004 Dec; 72(1):5-9. PubMed ID: 15531402
[TBL] [Abstract][Full Text] [Related]
4. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Sharma T
Br J Psychiatry Suppl; 1999; (38):44-51. PubMed ID: 10884899
[No Abstract] [Full Text] [Related]
5. Building a neurocognitive profile of thought disorder in schizophrenia using a standardized test battery.
Tan EJ; Rossell SL
Schizophr Res; 2014 Jan; 152(1):242-5. PubMed ID: 24291545
[TBL] [Abstract][Full Text] [Related]
6. Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
Kimhy D; Lauriola V; Bartels MN; Armstrong HF; Vakhrusheva J; Ballon JS; Sloan RP
Schizophr Res; 2016 Apr; 172(1-3):213-5. PubMed ID: 26852401
[No Abstract] [Full Text] [Related]
7. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications.
Purdon SE
J Psychiatry Neurosci; 2000 Mar; 25(2):108-16. PubMed ID: 10740984
[No Abstract] [Full Text] [Related]
8. Cognitive training for divergent thinking in schizophrenia: a pilot study.
Nemoto T; Yamazawa R; Kobayashi H; Fujita N; Chino B; Fujii C; Kashima H; Rassovsky Y; Green MF; Mizuno M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1533-6. PubMed ID: 19733608
[TBL] [Abstract][Full Text] [Related]
9. Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions.
Green MF
Am J Psychiatry; 2007 Jul; 164(7):992-4. PubMed ID: 17606645
[No Abstract] [Full Text] [Related]
10. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
Sarolta K; Pál C; István B
Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
[TBL] [Abstract][Full Text] [Related]
11. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
[TBL] [Abstract][Full Text] [Related]
12. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Heinrichs RW
Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
[No Abstract] [Full Text] [Related]
13. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
Cohen JD; Insel TR
Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
[No Abstract] [Full Text] [Related]
14. Another view of therapy for cognition in schizophrenia.
Carpenter WT; Gold JM
Biol Psychiatry; 2002 Jun; 51(12):969-71. PubMed ID: 12062880
[No Abstract] [Full Text] [Related]
15. The MATRICS consensus cognitive battery: what we know 6 years later.
Green MF; Harris JG; Nuechterlein KH
Am J Psychiatry; 2014 Nov; 171(11):1151-4. PubMed ID: 25756630
[No Abstract] [Full Text] [Related]
16. Researchers focus on recovery in schizophrenia.
Friedrich MJ
JAMA; 2014 Jul; 312(1):16-8. PubMed ID: 24942273
[No Abstract] [Full Text] [Related]
17. [Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?].
Faber G; van Gool AR; Smid HG; Wiersma D; van den Bosch RJ
Tijdschr Psychiatr; 2011; 53(2):107-17. PubMed ID: 21319067
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
19. [Cognition disorders and psychotic states].
Rouillon F
Encephale; 2002; 28 Spec No 2 Pt 2():S7-10. PubMed ID: 12587347
[No Abstract] [Full Text] [Related]
20. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
Kern RS; Nuechterlein KH; Green MF; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Mintz J; Seidman LJ; Stover E; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):214-20. PubMed ID: 18172018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]